Literature DB >> 7916931

Polyarteritis nodosa type vasculitis in a patient with familial Mediterranean fever treated with cyclosporin A.

M Henckes1, T Roskams, S Vanneste, B Van Damme, Y Vanrenterghem.   

Abstract

Patients with amyloidosis secondary to familial Mediterranean fever (FMF) are known to tolerate cyclosporin A poorly. We report a case of severe cyclosporin toxicity in a patient with FMF amyloidosis who underwent kidney transplantation. The clinical syndrome consisted of severe gastrointestinal, neuromuscular, and psychiatric disturbances. Histological examination of the transplanted kidney revealed vasculitis of the polyarteritis nodosa type. We hypothesize that FMF patients are more vulnerable to the acute vascular toxicity of cyclosporin due to defective inhibition of complement activation, leading to a widespread vasculitis of the polyarteritis nodosa type.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916931     DOI: 10.1007/bf00327159

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

Review 1.  Polyarteritis nodosa and deficiency of adenosine deaminase 2 - Shared genealogy, generations apart.

Authors:  Zhengping Huang; Tianwang Li; Peter A Nigrovic; Pui Y Lee
Journal:  Clin Immunol       Date:  2020-04-07       Impact factor: 3.969

Review 2.  Familial Mediterranean fever.

Authors:  Aysin Bakkaloglu
Journal:  Pediatr Nephrol       Date:  2003-06-27       Impact factor: 3.714

3.  Variable expression of vasculitis in siblings with familial Mediterranean fever.

Authors:  Bärbel Lange-Sperandio; Klaus Möhring; Frank Gutzler; Otto Mehls
Journal:  Pediatr Nephrol       Date:  2004-03-11       Impact factor: 3.714

4.  Renal transplantation in patients with familial Mediterranean fever.

Authors:  Emre Erdem; Ahmet Karatas; Coskun Kaya; Melda Dilek; Yarkın Kamil Yakupoglu; Nurol Arık; Tekin Akpolat
Journal:  Clin Rheumatol       Date:  2012-05-05       Impact factor: 2.980

Review 5.  Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes.

Authors:  Avinash Jain; Durga Prasanna Misra; Aman Sharma; Anupam Wakhlu; Vikas Agarwal; Vir Singh Negi
Journal:  Rheumatol Int       Date:  2017-10-14       Impact factor: 3.580

Review 6.  Current State of Precision Medicine in Primary Systemic Vasculitides.

Authors:  Erkan Demirkaya; Zehra Serap Arici; Micol Romano; Roberta Audrey Berard; Ivona Aksentijevich
Journal:  Front Immunol       Date:  2019-12-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.